Back to Journals » Cancer Management and Research » Volume 1 » Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma
Please verify you are not a robot.
Back to Journals » Cancer Management and Research » Volume 1 » Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma
Please verify you are not a robot.